Patients should be informed when AI systems are used in clinical trials

被引：9

作者：

Perni, Subha ^{[1
,2
,3
]}

Lehmann, Lisa Soleymani ^{[2
,4
]}

Bitterman, Danielle S. ^{[1
,2
]}

机构：

[1] Harvard Med Sch, Artificial Intelligence Med Program, Mass Gen Brigham, Boston, MA 02115 USA

[2] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA

[3] Univ Texas TMD Anderson Canc Ctr, Houston, TX USA

[4] Harvard Med Sch, Harvard TH Chan Sch Publ Hlth, Boston, MA USA

来源：

NATURE MEDICINE | 2023年 / 29卷 / 08期

关键词：

ARTIFICIAL-INTELLIGENCE;

D O I：

10.1038/s41591-023-02367-8

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1890 / 1891

页数：2

共 50 条

[31] WHEN SHOULD GRASS BE USED
BRADLEY, WG
RADIOLOGY, 1988, 169 (02) : 574 - 575
[32] THEOPHYLLINE - WHEN SHOULD IT BE USED
WEINBERGER, M
JOURNAL OF PEDIATRICS, 1993, 122 (03): : 403 - 405
[33] Aluminium-based adjuvants should not be used as placebos in clinical trials
Exley, Christopher
VACCINE, 2011, 29 (50) : 9289 - 9289
[34] Self-monitoring of blood pressure should be used in clinical trials
Baguet, JP
Mallion, JM
BLOOD PRESSURE MONITORING, 2002, 7 (01) : 55 - 59
[35] Which technique to measure blood pressure should be used in clinical trials?
Franz, IW
Müller, JFM
Palatini, P
Pessilla, AC
JOURNAL OF HYPERTENSION, 1998, 16 : S272 - S272
[36] When should placebo surgery as a control in clinical trials be carried out?
British Dental Journal, 2016, 220 (6) : 292 - 292
[37] The evolution of ways of deciding when clinical trials should stop recruiting
Armitage, Peter
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2014, 107 (01) : 34 - 39
[38] Discussion: Cognitive and behavioural assessment in clinical trials: when should they be done?
Thompson, P
EPILEPSY RESEARCH, 2001, 45 (1-3) : 159 - 161
[39] INFORMED CONSENT IN EUROPEAN MULTICENTER RANDOMIZED CLINICAL-TRIALS - ARE PATIENTS REALLY INFORMED
WILLIAMS, CJ
ZWITTER, M
EUROPEAN JOURNAL OF CANCER, 1994, 30A (07) : 907 - 910
[40] When should factorial designs be used for late-phase randomised controlled trials?
White, Ian R.
Szubert, Alexander J.
Choodari-Oskooei, Babak
Walker, A. Sarah
Parmar, Mahesh K. B.
CLINICAL TRIALS, 2024, 21 (02) : 162 - 170

← 1 2 3 4 5 →